United Kingdom · Series G startup
4 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$136Mraised across 4 rounds since 2008, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Reported by f2g.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
These 3 firms list F2G as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
F2G's investors include Astellas Venture Management, Merifin Capital, K Nominees, Novartis Venture Fund and Sunstone Life Science Ventures, and 4 more on record.
F2G has raised $136M across 4 rounds since 2008.
F2G's most recent round was a Series G of $34M in Jul 2021.
F2G's largest round on record is $60M (Undisclosed round), in Jun 2016.
F2G's first round on record, in Aug 2008, was backed by Astellas Venture Management, Merifin Capital and BankInvest Biomedical Venture and 1 others.
F2G's latest named round is a Series G, in Jul 2021.
F2G is based in the United Kingdom.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United Kingdom · 
